A structured evaluation of medical device potting and encapsulation methods begins with the failure mechanism the engineer is trying to control: moisture ingress, mechanical stress during thermal cycling, or bond loss at wire feedthroughs. Chemistry choice follows the requirements rather than the reverse. In published accelerated-aging work, silicone and unmodified potting approaches have underperformed overmolded systems with hermetic feedthroughs, while thin-film parylene and selected epoxy or silicone systems carry distinct processing and thickness constraints [1][3][7]. The decision should be made on documented test results under a defined aging model, not on material class alone. This article outlines the core decision points, the evidence limits of common reliability claims, and a concrete evaluation workflow using a hypothetical sensor module with a liquid-communications interface [6][5].
First, Fix the Failure Mode You Are Sealing Against
Potting and encapsulation are not interchangeable categories. Potting fills a housing or cavity to embed components, while encapsulation and conformal coating create the outer protective layer around an assembly or component. A hollow fiber filter uses static or centrifuge potting to anchor membranes and direct flow, which is a mechanical and sealing task distinct from protecting an exposed pacemaker circuit against bodily fluids [5][7]. Misclassifying the function can produce a device that survives sterilization but fails early under saline soak because the dominant ingress path was never addressed.
The sharpest documented example comes from a controlled comparison of three encapsulant groups on identical exposed test circuits. PDMS-encapsulated boards failed at 10 minutes and at 1 hour; an epoxy overmold with a hermetic feedthrough showed substantially better endurance against saline ingress [1][3]. The authors attributed the improvement specifically to the feedthrough, not to epoxy chemistry alone, since delamination or weak bonding between encapsulant and wires was a recognized failure source in the unmodified potting approach [1][4]. The practical lesson is to isolate whether failure originates through the bulk polymer, along an interface, or at a conductor exit before selecting a material.
Accelerated Aging Is a Reaction-Rate Estimate, Not a Clinical Result
Long-term reliability of polymer encapsulation is tested by soaking samples in elevated-temperature saline and translating accelerated failure time to estimated lifetime at body temperature using an Arrhenius relationship. A widely used simplification is the 10-degree rule, which assumes reaction rate doubles for each 10 degree increase in temperature and that aging approximates a first-order process. The same source recommends keeping acceleration temperature below 60 degrees Celsius because accuracy declines with greater deviation from 37 degrees, and higher temperatures can introduce unintended mechanisms [3].
This constraint means a low-temperature soak result cannot be confidently extrapolated decades into service. Thin-film systems illustrate the uncertainty. One atomic-layer-deposited alumina plus parylene stack did not fail for 185 days at 80 degrees, corresponding to an estimated 9.71 years at body temperature, while a similar construction powered at 5 V DC failed at 35 days. These are experimental benchmarks with defined sample and electrode configurations, not universal encapsulant ratings, and the original tables note asterisked results where samples survived the observation window without failing [3][6].
Suggested Workflow: A Moisture-Sensitive Sensor Module
Suppose a manufacturer must select an encapsulant for a non-powered sensor capsule with a saline-facing optical window and four conductor exits. Step one is defining the contact category and intended use under ISO 10993-1, because that drives the toxicological evaluation endpoint before mechanics [6]. Step two is building a test circuit that converts moisture ingress into a measurable electrical signature, similar to the exposed RC and diode test platform described for detecting corrosion and behavioral shifts in saline [1][4]. Step three is running the selected chemistries under the same accelerated soak protocol below 60 degrees, recording partial and complete failure timestamps rather than pass/fail outcomes [3].
A fourth step compares only configurations that share a feedthrough approach. The published method bonds a hermetic feedthrough into the CNC-machined mold before epoxy overmold, and the authors report this considerably improves endurance against liquid ingress from delamination or poor encapsulant-wire bonding. The method also allows complete freedom of shape without a custom molded cavity, at the cost of requiring a CNC mill and a demolding step. This is a prototype-friendly workflow, with the authors listing ejection systems and steel molds as possible next steps toward mass production [4][1]. The engineering decision remains local: a manufacturer with established injection molding may weigh process integration differently than a low-volume developer.
Chemistry Profiling Should Precede Vendor Selection
Each chemistry family presents a different balance of process viscosity, cure exotherm, flexibility, and thickness capability. Master Bond describes two-component thermally conductive and electrically insulative epoxy systems for potting and encapsulation with dimensional stability and low coefficient of thermal expansion, alongside silicone compounds for flexible, optically clear, low-outgassing applications. The supplier also lists UV and cyanoacrylate formulations for assembly tasks [2]. Kohesi Bond separates medical-grade epoxies from industrial resins on purity of raw materials and characterized toxicological profile, and recommends selection be driven by ISO 10993-1 device contact category before functional property comparisons [6].
Thin-film parylene represents a different point on the spectrum. Plasma Ruggedized Solutions applies parylene by chemical vapor deposition at thicknesses around 10 microns, describing it as a non-toxic FDA approved conformal coating suited to implantable devices where added weight must be minimal. The same source notes that parylene is not right for every project, which is consistent with documented material trade-offs: parylene can withstand saline soak for hundreds of days in certain experimental configurations, but its performance as a primary long-term implant barrier varies with substrate, defect density, and power state [7][3].
Product Claims Have Different Evidence Intensity
Vendor documentation should be classified by what it actually demonstrates. A Master Bond product page lists that specific formulations have been tested to ISO 10993-5 cytotoxicity and USP Class VI requirements, which speaks to biocompatibility screening but not to years-long moisture endurance in a powered implant. The page also states that certain epoxy compounds can be castable in thicknesses exceeding 2-3 inches and withstand repeated autoclaving, which are processing claims that would require validation in the device geometry, not a transferable barrier rating [2]. Epoxyset similarly lists general application categories and says its epoxy, urethane, and silicone systems protect against moisture, vibration, thermal cycling, and chemical exposure, without publishing device-specific soak data [8].
The peer-reviewed overmolding method is the strongest evidence anchor because it reports full test matrices, failure timestamps, and supplementary data for reproduction. The authors state the epoxy applied by their method is biocompatible on its own and that P3HT coating is optional, used to create a tailorable surface rather than to provide the primary barrier. They also note the total coating time until solvent visually evaporates is under 15 seconds, and Raman and FTIR analyses showed no residual chloroform in coated samples, which is a cleaning verification for the prototype wet-coating process rather than a long-term implant claim [4]. A structured evaluation weighs such evidence intensity instead of treating all marketing statements as equivalent.
Sources & references
- Low-cost and prototype-friendly method for biocompatible encapsulation of implantable electronics with epoxy overmolding, hermetic feedthroughs and P3HT coating - PMC · pmc.ncbi.nlm.nih.gov
- Epoxies for Medical Electronic Applications | MasterBond.com · www.masterbond.com
- Emerging Encapsulation Technologies for Long-Term Reliability of Microfabricated Implantable Devices - PMC · pmc.ncbi.nlm.nih.gov
- Low-cost and prototype-friendly method for biocompatible encapsulation of implantable electronics with epoxy overmolding, hermetic feedthroughs and P3HT coating | Scientific Reports · www.nature.com
- Medical Device Adhesives | Medical Filter & Potting Solutions · www.hbfuller.com
- Biocompatible Epoxy Potting for Medical Devices | Kohesi Bond · www.kohesibond.com
- Medical Device Coating Services | PRS · www.plasmarugged.com
- Potting and Encapsulating Compounds for Electronics | Epoxyset · epoxysetinc.com